APO Research
Talk to an analyst

APO RESEARCH · REPORT

Zika Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Zika Vaccines Market Analysis and Forecast 2026-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchZika Vaccines Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Zika Vaccines Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Zika Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zika Vaccines Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Zika Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Zika Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Zika Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Zika Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Zika Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Zika Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Zika Vaccines include Sanofi, GlaxoSmithKline, NewLink Genetics, Inovio Pharmaceuticals, Immunovaccine, Cerus Corporation and Bharat Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Zika Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Zika Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Zika Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Zika Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Zika Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Zika Vaccines sales, projected growth trends, production technology, application and end-user industry.

Zika Vaccines Segment by Company

Sanofi

GlaxoSmithKline

NewLink Genetics

Inovio Pharmaceuticals

Immunovaccine

Cerus Corporation

Bharat Biotech

Zika Vaccines Segment by Type

Therapeutic Vaccines

Preventive Vaccines

Zika Vaccines Segment by Application

Clinics

Hospitals

Ambulatory Surgery Centers

Others

Zika Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zika Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Zika Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Zika Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Zika Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Zika Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Therapeutic Vaccines Major Manufacturers Table 3. Preventive Vaccines Major Manufacturers Table 4. Global Zika Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinics Major Manufacturers Table 6. Hospitals Major Manufacturers Table 7. Ambulatory Surgery Centers Major Manufacturers Table 8. Others Major Manufacturers Table 9. Zika Vaccines Industry Trends Table 10. Zika Vaccines Industry Drivers Table 11. Zika Vaccines Industry Opportunities and Challenges Table 12. Zika Vaccines Industry Restraints Table 13. Global Zika Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Zika Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Zika Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Zika Vaccines Revenue Market Share by Region (2021-2026) Table 17. Global Zika Vaccines Revenue Market Share by Region (2027-2032) Table 18. Global Zika Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Zika Vaccines Sales by Region (2021-2026) & (k units) Table 20. Global Zika Vaccines Sales by Region (2027-2032) & (k units) Table 21. Global Zika Vaccines Sales Market Share by Region (2021-2026) Table 22. Global Zika Vaccines Sales Market Share by Region (2027-2032) Table 23. Global Zika Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Zika Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Zika Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Zika Vaccines Sales Market Share by Manufacturers (2021-2026) Table 27. Global Zika Vaccines Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Zika Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Zika Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Zika Vaccines Manufacturers, Product Type & Application Table 31. Global Zika Vaccines Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Zika Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Zika Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Zika Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Zika Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Zika Vaccines Revenue Market Share by Type (2021-2026) Table 38. Global Zika Vaccines Revenue Market Share by Type (2027-2032) Table 39. Global Zika Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Zika Vaccines Sales by Type (2021-2026) & (k units) Table 41. Global Zika Vaccines Sales by Type (2027-2032) & (k units) Table 42. Global Zika Vaccines Sales Market Share by Type (2021-2026) Table 43. Global Zika Vaccines Sales Market Share by Type (2027-2032) Table 44. Global Zika Vaccines Price by Type (2021-2026) & (US$/unit) Table 45. Global Zika Vaccines Price by Type (2027-2032) & (US$/unit) Table 46. Global Zika Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Zika Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Zika Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Zika Vaccines Revenue Market Share by Application (2021-2026) Table 50. Global Zika Vaccines Revenue Market Share by Application (2027-2032) Table 51. Global Zika Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Zika Vaccines Sales by Application (2021-2026) & (k units) Table 53. Global Zika Vaccines Sales by Application (2027-2032) & (k units) Table 54. Global Zika Vaccines Sales Market Share by Application (2021-2026) Table 55. Global Zika Vaccines Sales Market Share by Application (2027-2032) Table 56. Global Zika Vaccines Price by Application (2021-2026) & (US$/unit) Table 57. Global Zika Vaccines Price by Application (2027-2032) & (US$/unit) Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Sanofi Zika Vaccines Product Portfolio Table 62. Sanofi Recent Development Table 63. GlaxoSmithKline Company Information Table 64. GlaxoSmithKline Business Overview Table 65. GlaxoSmithKline Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. GlaxoSmithKline Zika Vaccines Product Portfolio Table 67. GlaxoSmithKline Recent Development Table 68. NewLink Genetics Company Information Table 69. NewLink Genetics Business Overview Table 70. NewLink Genetics Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. NewLink Genetics Zika Vaccines Product Portfolio Table 72. NewLink Genetics Recent Development Table 73. Inovio Pharmaceuticals Company Information Table 74. Inovio Pharmaceuticals Business Overview Table 75. Inovio Pharmaceuticals Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Inovio Pharmaceuticals Zika Vaccines Product Portfolio Table 77. Inovio Pharmaceuticals Recent Development Table 78. Immunovaccine Company Information Table 79. Immunovaccine Business Overview Table 80. Immunovaccine Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Immunovaccine Zika Vaccines Product Portfolio Table 82. Immunovaccine Recent Development Table 83. Cerus Corporation Company Information Table 84. Cerus Corporation Business Overview Table 85. Cerus Corporation Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Cerus Corporation Zika Vaccines Product Portfolio Table 87. Cerus Corporation Recent Development Table 88. Bharat Biotech Company Information Table 89. Bharat Biotech Business Overview Table 90. Bharat Biotech Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Bharat Biotech Zika Vaccines Product Portfolio Table 92. Bharat Biotech Recent Development Table 93. North America Zika Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Zika Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Zika Vaccines Sales by Type (2021-2026) & (k units) Table 96. North America Zika Vaccines Sales by Type (2027-2032) & (k units) Table 97. North America Zika Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 98. North America Zika Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 99. North America Zika Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Zika Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Zika Vaccines Sales by Application (2021-2026) & (k units) Table 102. North America Zika Vaccines Sales by Application (2027-2032) & (k units) Table 103. North America Zika Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 104. North America Zika Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 105. North America Zika Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Zika Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Zika Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Zika Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 109. North America Zika Vaccines Sales by Country (2021-2026) & (k units) Table 110. North America Zika Vaccines Sales by Country (2027-2032) & (k units) Table 111. North America Zika Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 112. North America Zika Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 113. United States Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 114. Canada Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 115. Mexico Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 116. Europe Zika Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Zika Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Zika Vaccines Sales by Type (2021-2026) & (k units) Table 119. Europe Zika Vaccines Sales by Type (2027-2032) & (k units) Table 120. Europe Zika Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 121. Europe Zika Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 122. Europe Zika Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Zika Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Zika Vaccines Sales by Application (2021-2026) & (k units) Table 125. Europe Zika Vaccines Sales by Application (2027-2032) & (k units) Table 126. Europe Zika Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 127. Europe Zika Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 128. Europe Zika Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Zika Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe Zika Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe Zika Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 132. Europe Zika Vaccines Sales by Country (2021-2026) & (k units) Table 133. Europe Zika Vaccines Sales by Country (2027-2032) & (k units) Table 134. Europe Zika Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 135. Europe Zika Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 136. Germany Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 137. France Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 138. U.K. Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 139. Italy Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 140. Russia Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 141. Spain Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 142. Netherlands Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 143. Switzerland Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 144. Sweden Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 145. Poland Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 146. China Zika Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 147. China Zika Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 148. China Zika Vaccines Sales by Type (2021-2026) & (k units) Table 149. China Zika Vaccines Sales by Type (2027-2032) & (k units) Table 150. China Zika Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 151. China Zika Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 152. China Zika Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 153. China Zika Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 154. China Zika Vaccines Sales by Application (2021-2026) & (k units) Table 155. China Zika Vaccines Sales by Application (2027-2032) & (k units) Table 156. China Zika Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 157. China Zika Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 158. Asia Zika Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Zika Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Zika Vaccines Sales by Type (2021-2026) & (k units) Table 161. Asia Zika Vaccines Sales by Type (2027-2032) & (k units) Table 162. Asia Zika Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 163. Asia Zika Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 164. Asia Zika Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Zika Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Zika Vaccines Sales by Application (2021-2026) & (k units) Table 167. Asia Zika Vaccines Sales by Application (2027-2032) & (k units) Table 168. Asia Zika Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 169. Asia Zika Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 170. Asia Zika Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Zika Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Zika Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Zika Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 174. Asia Zika Vaccines Sales by Country (2021-2026) & (k units) Table 175. Asia Zika Vaccines Sales by Country (2027-2032) & (k units) Table 176. Asia Zika Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 177. Asia Zika Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 178. Japan Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 179. South Korea Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 180. India Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 181. Australia Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 182. Taiwan Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Zika Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Zika Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Zika Vaccines Sales by Type (2021-2026) & (k units) Table 187. SAMEA Zika Vaccines Sales by Type (2027-2032) & (k units) Table 188. SAMEA Zika Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 189. SAMEA Zika Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 190. SAMEA Zika Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Zika Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Zika Vaccines Sales by Application (2021-2026) & (k units) Table 193. SAMEA Zika Vaccines Sales by Application (2027-2032) & (k units) Table 194. SAMEA Zika Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 195. SAMEA Zika Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 196. SAMEA Zika Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Zika Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Zika Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Zika Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 200. SAMEA Zika Vaccines Sales by Country (2021-2026) & (k units) Table 201. SAMEA Zika Vaccines Sales by Country (2027-2032) & (k units) Table 202. SAMEA Zika Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 203. SAMEA Zika Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 204. Brazil Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 205. Argentina Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 206. Chile Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 207. Colombia Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 208. Peru Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 210. Israel Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 211. UAE Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 212. Turkey Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 213. Iran Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 214. Egypt Zika Vaccines Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Zika Vaccines Distributors List Table 218. Zika Vaccines Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Zika Vaccines Image Figure 2. Global Zika Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zika Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Therapeutic Vaccines Image Figure 5. Preventive Vaccines Image Figure 6. Global Zika Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Zika Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinics Image Figure 9. Hospitals Image Figure 10. Ambulatory Surgery Centers Image Figure 11. Others Image Figure 12. Global Zika Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Zika Vaccines Revenue (2021-2032) & (US$ Million) Figure 14. Global Zika Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Zika Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Zika Vaccines Revenue Market Share by Region (2021-2032) Figure 17. Global Zika Vaccines Sales (2021-2032) & (k units) Figure 18. Global Zika Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Zika Vaccines Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Zika Vaccines Sales YoY (2021-2032) & (k units) Figure 21. Europe Zika Vaccines Sales YoY (2021-2032) & (k units) Figure 22. China Zika Vaccines Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Zika Vaccines Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Zika Vaccines Sales YoY (2021-2032) & (k units) Figure 25. Global Zika Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Zika Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Zika Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Zika Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Zika Vaccines Revenue Market Share by Type (2021-2032) Figure 31. Global Zika Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Zika Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Zika Vaccines Sales Market Share by Type (2021-2032) Figure 34. Global Zika Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Zika Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Zika Vaccines Revenue Market Share by Application (2021-2032) Figure 37. Global Zika Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Zika Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Zika Vaccines Sales Market Share by Application (2021-2032) Figure 40. North America Zika Vaccines Revenue Share by Type (2021-2032) Figure 41. North America Zika Vaccines Sales Share by Type (2021-2032) Figure 42. North America Zika Vaccines Revenue Share by Application (2021-2032) Figure 43. North America Zika Vaccines Sales Share by Application (2021-2032) Figure 44. North America Zika Vaccines Revenue Share by Country (2021-2032) Figure 45. North America Zika Vaccines Sales Share by Country (2021-2032) Figure 46. Europe Zika Vaccines Revenue Share by Type (2021-2032) Figure 47. Europe Zika Vaccines Sales Share by Type (2021-2032) Figure 48. Europe Zika Vaccines Revenue Share by Application (2021-2032) Figure 49. Europe Zika Vaccines Sales Share by Application (2021-2032) Figure 50. Europe Zika Vaccines Revenue Share by Country (2021-2032) Figure 51. Europe Zika Vaccines Sales Share by Country (2021-2032) Figure 52. China Zika Vaccines Revenue Share by Type (2021-2032) Figure 53. China Zika Vaccines Sales Share by Type (2021-2032) Figure 54. China Zika Vaccines Revenue Share by Application (2021-2032) Figure 55. China Zika Vaccines Sales Share by Application (2021-2032) Figure 56. Asia Zika Vaccines Revenue Share by Type (2021-2032) Figure 57. Asia Zika Vaccines Sales Share by Type (2021-2032) Figure 58. Asia Zika Vaccines Revenue Share by Application (2021-2032) Figure 59. Asia Zika Vaccines Sales Share by Application (2021-2032) Figure 60. Asia Zika Vaccines Revenue Share by Country (2021-2032) Figure 61. Asia Zika Vaccines Sales Share by Country (2021-2032) Figure 62. SAMEA Zika Vaccines Revenue Share by Type (2021-2032) Figure 63. SAMEA Zika Vaccines Sales Share by Type (2021-2032) Figure 64. SAMEA Zika Vaccines Revenue Share by Application (2021-2032) Figure 65. SAMEA Zika Vaccines Sales Share by Application (2021-2032) Figure 66. SAMEA Zika Vaccines Revenue Share by Country (2021-2032) Figure 67. SAMEA Zika Vaccines Sales Share by Country (2021-2032) Figure 68. Zika Vaccines Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Zika Vaccines Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Therapeutic Vaccines
  • Preventive Vaccines
Applications
  • Clinics
  • Hospitals
  • Ambulatory Surgery Centers
  • Others
Companies covered
  • Sanofi
  • GlaxoSmithKline
  • NewLink Genetics
  • Inovio Pharmaceuticals
  • Immunovaccine
  • Cerus Corporation
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Zika Vaccines Market by Type
  3. 1.2.1 Global Zika Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Therapeutic Vaccines
  5. 1.2.3 Preventive Vaccines
  6. 1.3 Zika Vaccines Market by Application
  7. 1.3.1 Global Zika Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinics
  9. 1.3.3 Hospitals
  10. 1.3.4 Ambulatory Surgery Centers
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Zika Vaccines Market Dynamics
  1. 2.1 Zika Vaccines Industry Trends
  2. 2.2 Zika Vaccines Industry Drivers
  3. 2.3 Zika Vaccines Industry Opportunities and Challenges
  4. 2.4 Zika Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Zika Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Zika Vaccines Revenue by Region
  3. 3.2.1 Global Zika Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Zika Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Zika Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Zika Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Zika Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Zika Vaccines Sales by Region
  9. 3.4.1 Global Zika Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Zika Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Zika Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Zika Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Zika Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Zika Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Zika Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Zika Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Zika Vaccines Sales by Manufacturers
  6. 4.2.1 Global Zika Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Zika Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Zika Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Zika Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Zika Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Zika Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Zika Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Zika Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Zika Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Zika Vaccines Tier 1, Tier 2, and Tier 3
5 Zika Vaccines Market by Type
  1. 5.1 Global Zika Vaccines Revenue by Type
  2. 5.1.1 Global Zika Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Zika Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Zika Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Zika Vaccines Sales by Type
  6. 5.2.1 Global Zika Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Zika Vaccines Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Zika Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Zika Vaccines Price by Type
6 Zika Vaccines Market by Application
  1. 6.1 Global Zika Vaccines Revenue by Application
  2. 6.1.1 Global Zika Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Zika Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Zika Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Zika Vaccines Sales by Application
  6. 6.2.1 Global Zika Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Zika Vaccines Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Zika Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Zika Vaccines Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Zika Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Zika Vaccines Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 GlaxoSmithKline
  8. 7.2.1 GlaxoSmithKline Company Information
  9. 7.2.2 GlaxoSmithKline Business Overview
  10. 7.2.3 GlaxoSmithKline Zika Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GlaxoSmithKline Zika Vaccines Product Portfolio
  12. 7.2.5 GlaxoSmithKline Recent Developments
  13. 7.3 NewLink Genetics
  14. 7.3.1 NewLink Genetics Company Information
  15. 7.3.2 NewLink Genetics Business Overview
  16. 7.3.3 NewLink Genetics Zika Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 NewLink Genetics Zika Vaccines Product Portfolio
  18. 7.3.5 NewLink Genetics Recent Developments
  19. 7.4 Inovio Pharmaceuticals
  20. 7.4.1 Inovio Pharmaceuticals Company Information
  21. 7.4.2 Inovio Pharmaceuticals Business Overview
  22. 7.4.3 Inovio Pharmaceuticals Zika Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Inovio Pharmaceuticals Zika Vaccines Product Portfolio
  24. 7.4.5 Inovio Pharmaceuticals Recent Developments
  25. 7.5 Immunovaccine
  26. 7.5.1 Immunovaccine Company Information
  27. 7.5.2 Immunovaccine Business Overview
  28. 7.5.3 Immunovaccine Zika Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Immunovaccine Zika Vaccines Product Portfolio
  30. 7.5.5 Immunovaccine Recent Developments
  31. 7.6 Cerus Corporation
  32. 7.6.1 Cerus Corporation Company Information
  33. 7.6.2 Cerus Corporation Business Overview
  34. 7.6.3 Cerus Corporation Zika Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Cerus Corporation Zika Vaccines Product Portfolio
  36. 7.6.5 Cerus Corporation Recent Developments
  37. 7.7 Bharat Biotech
  38. 7.7.1 Bharat Biotech Company Information
  39. 7.7.2 Bharat Biotech Business Overview
  40. 7.7.3 Bharat Biotech Zika Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bharat Biotech Zika Vaccines Product Portfolio
  42. 7.7.5 Bharat Biotech Recent Developments
8 North America
  1. 8.1 North America Zika Vaccines Market Size by Type
  2. 8.1.1 North America Zika Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Zika Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Zika Vaccines Price by Type (2021-2032)
  5. 8.2 North America Zika Vaccines Market Size by Application
  6. 8.2.1 North America Zika Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Zika Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Zika Vaccines Price by Application (2021-2032)
  9. 8.3 North America Zika Vaccines Market Size by Country
  10. 8.3.1 North America Zika Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Zika Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Zika Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Zika Vaccines Market Size by Type
  2. 9.1.1 Europe Zika Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Zika Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Zika Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Zika Vaccines Market Size by Application
  6. 9.2.1 Europe Zika Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Zika Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Zika Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Zika Vaccines Market Size by Country
  10. 9.3.1 Europe Zika Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Zika Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Zika Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Zika Vaccines Market Size by Type
  2. 10.1.1 China Zika Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Zika Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Zika Vaccines Price by Type (2021-2032)
  5. 10.2 China Zika Vaccines Market Size by Application
  6. 10.2.1 China Zika Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Zika Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Zika Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Zika Vaccines Market Size by Type
  2. 11.1.1 Asia Zika Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Zika Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Zika Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Zika Vaccines Market Size by Application
  6. 11.2.1 Asia Zika Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Zika Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Zika Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Zika Vaccines Market Size by Country
  10. 11.3.1 Asia Zika Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Zika Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Zika Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Zika Vaccines Market Size by Type
  2. 12.1.1 SAMEA Zika Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Zika Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Zika Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Zika Vaccines Market Size by Application
  6. 12.2.1 SAMEA Zika Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Zika Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Zika Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Zika Vaccines Market Size by Country
  10. 12.3.1 SAMEA Zika Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Zika Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Zika Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Zika Vaccines Value Chain Analysis
  2. 13.1.1 Zika Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Zika Vaccines Production Mode & Process
  6. 13.2 Zika Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Zika Vaccines Distributors
  9. 13.2.3 Zika Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst